214 related articles for article (PubMed ID: 26953036)
1. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
Kim M
Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
[No Abstract] [Full Text] [Related]
2. Vogt-Koyanagi-Harada disease after stapedotomy.
Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada disease in 3-year-old boy.
Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
[No Abstract] [Full Text] [Related]
4. Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
Yang HK; Park KH; Kim JS; Hwang JM
Can J Ophthalmol; 2014 Apr; 49(2):e54-6. PubMed ID: 24767242
[No Abstract] [Full Text] [Related]
5. Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
Tien MC; Teoh SC
Can J Ophthalmol; 2009 Apr; 44(2):211-2. PubMed ID: 19491962
[No Abstract] [Full Text] [Related]
6. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
[TBL] [Abstract][Full Text] [Related]
9. Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy.
Gallagher MJ; Yilmaz T; Foster CS
Ophthalmic Surg Lasers Imaging; 2009; 40(3):345-7. PubMed ID: 19485308
[No Abstract] [Full Text] [Related]
10. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
Montero JA; Sanchis ME; Fernandez-Munoz M
J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
[TBL] [Abstract][Full Text] [Related]
12. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
Li AS; Tang PH; Do DV
JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
[No Abstract] [Full Text] [Related]
13. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
Koong LR; Chee WK; Toh ZH; Ng XL; Agrawal R; Ho SL
Ocul Immunol Inflamm; 2021 Aug; 29(6):1212-1215. PubMed ID: 34505819
[TBL] [Abstract][Full Text] [Related]
15. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Maruyama Y; Kishi S
Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
[TBL] [Abstract][Full Text] [Related]
16. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
18. Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease.
Morita C; Sakata VM; Rodriguez EE; Abdallah SF; Lavezzo MM; da Silva FT; Machado CG; Oyamada MK; Hirata CE; Yamamoto JH
Acta Ophthalmol; 2016 Dec; 94(8):e820-e821. PubMed ID: 27368955
[No Abstract] [Full Text] [Related]
19. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
20. Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease.
Errera MH; Levinson RD; Fardeau C; Thomas D; Cohen D; Navarro A; Héron E; Paques M; Pavesio C; Sahel JA; Westcott MC; Gaudric A; LeHoang P; Bodaghi B
Acta Ophthalmol; 2015 Sep; 93(6):e509-10. PubMed ID: 25604241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
